Recognizing and understanding heterogeneity is crucial for developing effective personalized therapies. It helps in identifying which patient subgroups are more likely to benefit from specific treatments, thereby improving overall outcomes. Additionally, it facilitates the development of targeted therapies that can address the unique characteristics of different cancer cells.
